Jiangsu Aidea Pharmaceutical Co Ltd Free Cash Flow Generation Index

Latest as of September 2025: 0.49x

Jiangsu Aidea Pharmaceutical Co Ltd free cash flow generation index. Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Free Cash Flow Generation Index of 0.49x as of September 2025. Free cash flow of CN¥1.76 Million represents 0% of operating cash flow (CN¥3.56 Million). Check 688488 financial resilience to evaluate the company's liquid asset resilience ratio.

FCF Generation Index

0.49x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥1.76 Million
CNY

Operating Cash Flow

CN¥3.56 Million
CNY

Capital Expenditures

CN¥1.81 Million
CNY

Free Cash Flow Generation Index of Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)

Free cash flow generation index of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. Historical FCF Generation Index trend for Jiangsu Aidea Pharmaceutical Co Ltd across 4 annual periods. Explore how much does Jiangsu Aidea Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Jiangsu Aidea Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2016–2025)

Jiangsu Aidea Pharmaceutical Co Ltd free cash flow generation index by year from 2016 to 2025. Year-by-year Free Cash Flow Generation Index for Jiangsu Aidea Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 688488 operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 -1.72x CN¥-30.30 Million CN¥17.63 Million CN¥47.93 Million ▼ -802.6%
2020 0.24x CN¥13.74 Million CN¥56.17 Million CN¥42.43 Million ▼ -39.4%
2019 0.40x CN¥22.70 Million CN¥56.20 Million CN¥33.50 Million ▲ +131.8%
2016 -1.27x CN¥-39.72 Million CN¥31.29 Million CN¥71.01 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).